NCT06868238 2026-02-18
Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)
University of Florida
Phase 2 Withdrawn
Clinical Trials
10 trialsNCT06912763 2026-01-26
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06092892 2025-12-10
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
Cedars-Sinai Medical Center
Phase 2 Recruiting
NCT00827372 2023-10-16
A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer
Indiana University
Phase 2 Completed
NCT03776721 2021-06-25
Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting
Odense University Hospital
Phase 2 Completed
NCT01276054 2014-08-01
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.
University of Southern California
Phase 2 Terminated
NCT00780312 2013-07-02
HOHF
Rigshospitalet, Denmark
Phase 2 Completed
NCT01003951 2012-08-16
Acupuncture for the Treatment of Chronic Lymphedema
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01318785 2011-09-07
BF09-PH-01
University Medicine Greifswald
Phase 2 Unknown
NCT00188604 2010-08-13
The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer
University Health Network, Toronto
Phase 2 Completed